Basis: (FMP quote price / unrounded diluted TTM EPS) / explicitly dated EPS growth percent. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-09-16T00:15:35.299Z.
Calculation as of: 2026-09-16T00:15:35.299Z.
Quote observation: 2026-09-15T20:00:03.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: cbfca69bfb324fb5f19eba08877f0fd102dd0a8c0ba522143f4e1d01ec351501
PEG RATIO
N/A
Cigna Corporation
Market Cap
$76.34B
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| Cigna Corporation (CI) | $76.34B | N/A |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $79.75B | N/A |
| Boston Scientific Corporation (BSX)vs › | $65.21B | N/A |
| Cencora, Inc. (COR)vs › | $62.90B | N/A |
| Elevance Health Inc. (ELV)vs › | $90.55B | N/A |
| HCA Healthcare, Inc. (HCA)vs › | $91.76B | N/A |
| Moderna, Inc. (MRNA)vs › | $57.05B | N/A |
| Cardinal Health, Inc. (CAH)vs › | $54.49B | N/A |
| GSK plc (GSK)vs › | $100.20B | N/A |
| Becton, Dickinson and Company (BDX)vs › | $51.23B | N/A |
PEG Ratio
N/A
P/E Ratio
12.0
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
